News
StockStory.org on MSN9h
Reflecting On Immuno-Oncology Stocks’ Q4 Earnings: Regeneron (NASDAQ:REGN)Looking back on immuno-oncology stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Regeneron ...
Roughly 10 weeks ago, Christi Grimm was the inspector general and top watchdog monitoring the Department of Health and Human ...
Charles River Laboratories, Amgen and Jazz Pharmaceuticals, among others. Regeneron CEO Leonard Schleifer saw his pay decline last year, with his total salary dropping from $8.18 million in 2023 to $6 ...
Regeneron is the second pharma group to sign up for access to data from a remote study run by health technology firm Koneksa that is exploring the use of digital biomarkers to track patients with ...
Regeneron and Illumina have joined a major investment in health data specialist Truveta that will support the creation of a major new genome project. The two companies, along with 17 US health ...
Conference Call Information Participants may access the conference call live via webcast on the ’Investors and Media’ page of Regeneron’s websi Regeneron Pharmaceuticals, Inc. and Society ...
Given that he's been championing tariffs against countries 'ripping off' the US ever since the 1980s, the imposition of penalties on exporters to America appeared to be the one policy that Donald ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results